Biogen Inc. (BIIB)

Last Closing Price: 216.13 (2024-05-01)

Net Income (Annual)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Biogen Inc. (BIIB) had Net Income of $1.16B for the most recently reported fiscal year, ending 2023-12-31.

Figures for fiscal year ending 2023-12-31
Income Statement Financials
$9.84B
Net Income
$1.16B
$2.53B
$7.30B
$8.22B
$1.61B
$-315.50M
$1.30B
$1.30B
$1.16B
$1.16B
$1.16B
$1.16B
$1.61B
$2.14B
144.70M
145.60M
$8.02
$7.97
Balance Sheet Financials
$6.86B
$3.31B
$19.99B
$26.84B
$3.43B
$6.79B
$8.61B
$12.05B
$14.80B
$217.20M
$14.80B
144.90M
Cash Flow Statement Financials
$1.55B
$-4.10B
$149.30M
$3.42B
$1.05B
$-2.37B
$264.20M
--
--
Fundamental Metrics & Ratios
2.00
--
--
0.31
0.47
74.24%
16.39%
16.39%
21.74%
13.18%
11.81%
$1.27B
--
--
--
0.37
1.00
5.91
61.75
7.85%
534.76%
4.33%
5.38%
$102.14
$8.72
$10.63